347 related articles for article (PubMed ID: 9724387)
1. Radioimmunotherapy with alpha-emitting nuclides.
McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
3. Advancements in cancer therapy with alpha-emitters: a review.
Imam SK
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):271-8. PubMed ID: 11516878
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.
Zalutsky MR; Bigner DD
Acta Oncol; 1996; 35(3):373-9. PubMed ID: 8679269
[TBL] [Abstract][Full Text] [Related]
5. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
6. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
8. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
Vaidyanathan G; Zalutsky MR
Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
[TBL] [Abstract][Full Text] [Related]
9. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Ferrier MG; Radchenko V
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
[No Abstract] [Full Text] [Related]
10. Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
Featherstone C
Mol Med Today; 1997 Jun; 3(6):232-3. PubMed ID: 9211409
[No Abstract] [Full Text] [Related]
11. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
Lindegren S; Frost SH
Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
[TBL] [Abstract][Full Text] [Related]
12. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
Mirzadeh S
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270
[TBL] [Abstract][Full Text] [Related]
13. Actinium-225 in targeted alpha-particle therapeutic applications.
Scheinberg DA; McDevitt MR
Curr Radiopharm; 2011 Oct; 4(4):306-20. PubMed ID: 22202153
[TBL] [Abstract][Full Text] [Related]
14. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
16. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
17. Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images.
Akabani G; Kennel SJ; Zalutsky MR
J Nucl Med; 2003 May; 44(5):792-805. PubMed ID: 12732682
[TBL] [Abstract][Full Text] [Related]
18. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
19. Radionuclides for radioimmunotherapy: criteria for selection.
Geerlings MW
Int J Biol Markers; 1993; 8(3):180-6. PubMed ID: 8277210
[TBL] [Abstract][Full Text] [Related]
20. Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies.
Jurcic JG
Curr Radiopharm; 2018; 11(3):192-199. PubMed ID: 29793418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]